Data / Research funding / Translational Research
Translational Research: 16,081 NIH awards ($36B) and 225 NSF awards ($562.2M) to 1,891 organizations
16,081 NIH awards ($36B) and 225 NSF awards ($562.2M) in the NIH spending category Translational Research and the NSF reference name Translational Research, to 1,891 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category and NSF reference name
Awards
The 500 largest of 16,306 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $472,070,715 | December 1, 2024 | November 30, 2025 | CURRIER, JUDITH S. | reporter.nih.gov |
| HIV Vaccines Clinical Trials Network Leadership and Operations Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $244,071,463 | June 29, 2006 | November 30, 2027 | COREY, LAWRENCE | reporter.nih.gov |
| HIV Prevention Trials Network Leadership and Operations Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $213,590,410 | June 1, 2006 | November 30, 2027 | COHEN, MYRON SCOTT | reporter.nih.gov |
| Immune Tolerance Network | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $203,912,588 | February 1, 2014 | January 31, 2028 | BUCKNER, JANE HOYT | reporter.nih.gov |
| HIV and Other Infectious Diseases Clinical Research Support Services (CRSS) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $198,645,463 | August 15, 2025 | August 14, 2026 | STOKES, BAMBRA | reporter.nih.gov |
| HIV Vaccine Trials Network Laboratory Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $177,480,054 | June 29, 2006 | November 30, 2027 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| SDMC: HIV Vaccine Trials Network | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $156,744,802 | June 29, 2006 | November 30, 2027 | GILBERT, PETER B. | reporter.nih.gov |
| Consortium for HIV/AIDS Vaccine Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $145,502,241 | July 1, 2019 | June 30, 2026 | BURTON, DENNIS R. | reporter.nih.gov |
| Induction of protective antibodies for HIV vaccine development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $143,048,158 | July 15, 2019 | June 30, 2026 | HAYNES, BARTON F. | reporter.nih.gov |
| COG NCTN Year 12 BIQSFP Progress Report | NIH | National Cancer Institute | 2021 to 2025 | $141,250,012 | April 11, 2014 | February 28, 2026 | HAWKINS, DOUGLAS S. | reporter.nih.gov |
| Consortium for Advancing Management and Prevention of Cancer in People with HIV | NIH | National Cancer Institute | 2021 to 2025 | $106,635,299 | August 29, 2006 | August 31, 2030 | SPARANO, JOSEPH A. | reporter.nih.gov |
| Data Coordinating Center for Type 1 Diabetes TrialNet | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $99,686,705 | September 30, 2015 | May 31, 2030 | KRISCHER, JEFFREY P | reporter.nih.gov |
| ECOG-ACRIN NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $95,697,835 | August 1, 2014 | July 31, 2026 | WAGNER, LYNNE I. | reporter.nih.gov |
| Alzheimer's Disease Neuroimaging Initiative (ADNI4) | NIH | National Institute on Aging | 2022 to 2025 | $95,332,786 | September 30, 2004 | July 31, 2028 | WEINER, MICHAEL W | reporter.nih.gov |
| NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: AVIAN INFLUENZA RESEARCH | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $91,354,067 | April 1, 2021 | January 14, 2027 | WEBBY, RICHARD | reporter.nih.gov |
| AI-driven Structure-enabled Antiviral Platform (ASAP) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $89,845,851 | May 16, 2022 | August 31, 2027 | CHODERA, JOHN DAMON | reporter.nih.gov |
| CANCER THERAPY EVALUATION PROGRAM INFORMATICS & COMPUTER SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $86,933,457 | July 1, 2022 | June 30, 2026 | RAJU, SUDHIR | reporter.nih.gov |
| Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $84,840,845 | June 29, 2006 | November 30, 2027 | HUGHES, MICHAEL DAVID | reporter.nih.gov |
| DIAN-TU Primary Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $79,373,454 | September 15, 2018 | May 31, 2026 | MCDADE, ERIC MARTIN | reporter.nih.gov |
| Antibacterial Resistance Leadership Group (ARLG) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $78,031,274 | June 1, 2013 | November 30, 2026 | FOWLER, VANCE G. | reporter.nih.gov |
| IMPAACT Leadership Group | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $77,468,129 | December 1, 2024 | November 30, 2027 | NACHMAN, SHARON A | reporter.nih.gov |
| TASK ORDER 4A SITE STUDY SETUP: CTSU IDIQ | NIH | National Cancer Institute | 2022 to 2025 | $77,467,748 | August 1, 2022 | July 31, 2026 | PATRICHUK, LUCILLE | reporter.nih.gov |
| HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $74,729,762 | June 29, 2006 | November 30, 2027 | DONNELL, DEBORAH J | reporter.nih.gov |
| Clinical and Translational Science Award | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $73,235,012 | August 18, 2015 | May 19, 2026 | BREDELLA, MIRIAM ANTOINETTE | reporter.nih.gov |
| COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA VACCINE RESEARCH | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $72,825,966 | September 10, 2019 | September 24, 2026 | KRAMMER, FLORIAN | reporter.nih.gov |
| ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING OF CANDIDATE MEDICAL COUNTERMEASURES (MCMS) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $72,520,576 | September 30, 2025 | September 29, 2026 | reporter.nih.gov | |
| California National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $70,585,773 | May 1, 1997 | April 30, 2028 | ATKINSON, SIMON J. | reporter.nih.gov |
| Support for National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $70,297,738 | May 1, 1997 | April 30, 2029 | NAGEL, BONNIE J. | reporter.nih.gov |
| Washington National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $66,616,318 | June 10, 1997 | April 30, 2027 | OSTENDORF, MARI | reporter.nih.gov |
| NIDA Clinical Trials Network: New York Node (CTN-0139, CTN-0155, CTN-Biostats) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $66,452,521 | March 1, 2025 | February 29, 2032 | MCNEELY, JENNIFER | reporter.nih.gov |
| NCI Early Career Cancer Clinical Investigator Award | NIH | National Cancer Institute | 2021 to 2025 | $65,560,307 | March 10, 1997 | November 30, 2026 | EBERT, BENJAMIN LEVINE | reporter.nih.gov |
| Alliance for Clinical Trials in Oncology Operations Center - GY11 BIQSFP Funded Extension | NIH | National Cancer Institute | 2021 to 2025 | $65,300,792 | April 17, 2014 | February 28, 2026 | PIANTADOSI, STEVEN | reporter.nih.gov |
| Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $63,155,364 | December 5, 2019 | November 30, 2026 | STEPHENS, DAVID S | reporter.nih.gov |
| ProNET: Psychosis-Risk Outcomes Network | NIH | National Institute of Mental Health | 2021 to 2025 | $61,984,741 | September 8, 2020 | May 31, 2026 | WOODS, SCOTT W | reporter.nih.gov |
| Emory National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $59,605,748 | May 1, 1997 | April 30, 2026 | LEE, JOON SUP | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $59,316,664 | August 28, 1996 | June 30, 2026 | DRAETTA, GIULIO FRANCESCO | reporter.nih.gov |
| SDMC - IMPAACT Leadership Group | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $59,233,299 | June 29, 2006 | November 30, 2027 | SHAPIRO, DAVID ERIC | reporter.nih.gov |
| CTN New England Consortium Node | NIH | National Institute on Drug Abuse | 2021 to 2025 | $58,365,118 | March 1, 2025 | February 29, 2032 | D'ONOFRIO, GAIL | reporter.nih.gov |
| GY11 BIQSFP Supplement Request | NIH | National Cancer Institute | 2021 to 2025 | $57,110,172 | March 17, 2025 | February 28, 2026 | BLANKE, CHARLES D. | reporter.nih.gov |
| AIDS Clinical Trial Group Laboratory Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $56,714,107 | January 1, 2014 | November 30, 2027 | ALDROVANDI, GRACE M | reporter.nih.gov |
| NRG Oncology NCORP Research Base-BIQSFP | NIH | National Cancer Institute | 2021 to 2025 | $54,340,726 | July 11, 2025 | July 31, 2026 | BRUNER, DEBORAH WATKINS | reporter.nih.gov |
| CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $53,879,677 | September 10, 2019 | September 9, 2026 | ROSS, TED | reporter.nih.gov |
| Yale Clinical and Translational Science Award | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $53,543,083 | July 1, 2016 | March 31, 2027 | SMITH, BRIAN RICHARD | reporter.nih.gov |
| University of Pittsburgh Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $52,585,662 | July 12, 2016 | July 31, 2026 | REIS, STEVEN E | reporter.nih.gov |
| Vanderbilt Institute for Clinical and Translational Research (VICTR) | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $52,517,120 | June 1, 2017 | February 28, 2027 | SELF, WESLEY H | reporter.nih.gov |
| Collaborative Influenza Vaccine Innovation Centers (CIVICs) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $52,452,735 | September 10, 2019 | September 9, 2026 | MOODY, TONY | reporter.nih.gov |
| Tulane National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $52,341,995 | May 9, 1997 | April 30, 2028 | HAMM, L LEE | reporter.nih.gov |
| Institute of Translational Health Sciences | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $51,856,326 | June 1, 2017 | February 28, 2027 | AMORY, JOHN K. | reporter.nih.gov |
| DAIDS Quality Assurance, Quality Control and Inspection Readiness Support Services | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $51,529,857 | April 17, 2025 | April 16, 2026 | reporter.nih.gov | |
| Clinical and Translational Science Award | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $51,389,849 | August 1, 2022 | May 31, 2027 | REILLY, MUREDACH P | reporter.nih.gov |
| Institutional Clinical and Translational Science Award | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $51,372,550 | July 1, 2016 | July 31, 2026 | FITZGERALD, GARRET A | reporter.nih.gov |
| Access for All in ALS (ALL ALS) West Clinical Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $51,203,440 | September 25, 2023 | June 30, 2027 | BOWSER, ROBERT P | reporter.nih.gov |
| Wisconsin National Primate Research Center Support | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $50,984,900 | June 10, 1997 | April 30, 2027 | GREJNER-BRZEZINSKA, DOROTA A. | reporter.nih.gov |
| Alliance NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $50,260,118 | August 1, 2014 | July 31, 2026 | PASKETT, ELECTRA D. | reporter.nih.gov |
| DIAN-TU: Tau Next Generation Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $49,839,335 | September 15, 2020 | May 31, 2027 | BATEMAN, RANDALL J | reporter.nih.gov |
| Washington University Institute of Clinical and Translational Sciences | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $49,526,150 | June 19, 2017 | February 28, 2027 | POWDERLY, WILLIAM G. | reporter.nih.gov |
| Abramson Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $48,027,008 | January 15, 1997 | May 31, 2026 | VONDERHEIDE, ROBERT H. | reporter.nih.gov |
| Georgia Clinical & Translational Science Alliance (Georgia CTSA) | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $47,579,618 | September 22, 2017 | July 31, 2027 | TAYLOR, WILLIAM ROBERT | reporter.nih.gov |
| The Southwest National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $46,064,371 | June 6, 1999 | April 30, 2026 | SCHLESINGER, LARRY S. | reporter.nih.gov |
| UCLA Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $45,706,933 | July 1, 2016 | May 31, 2027 | BROWN, ARLEEN F. | reporter.nih.gov |
| SUPPORT SERVICES OF THE HIV AIDS CLINICAL TRIAL NETWORKS | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $45,166,816 | November 30, 2022 | November 29, 2025 | DRIVER, BARBARA | reporter.nih.gov |
| Clinical and Translational Science Center | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $44,995,547 | September 5, 2017 | June 30, 2027 | IMPERATO-MCGINLEY, JULIANNE L | reporter.nih.gov |
| Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $44,959,734 | August 13, 2025 | November 30, 2026 | KOTLOFF, KAREN L. | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2022 to 2025 | $44,496,290 | January 1, 1997 | December 31, 2029 | LYNCH, THOMAS JAMES | reporter.nih.gov |
| Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component B: Vaccine Manufacturing and Toxicology Core | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $44,296,051 | August 26, 2019 | March 13, 2028 | DENNY, THOMAS | reporter.nih.gov |
| OCTRI - Culturally sensitive model to improve cervical cancer screening uptake in Spanish-speaking and American Indian/Alaska Native communities | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $43,274,051 | September 2, 2017 | July 31, 2026 | MORRIS, CYNTHIA D | reporter.nih.gov |
| DRCR Retina Network | NIH | National Eye Institute | 2021 to 2025 | $43,226,123 | September 30, 2002 | December 31, 2028 | GLASSMAN, ADAM R | reporter.nih.gov |
| Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $42,377,367 | July 18, 2016 | June 30, 2026 | JACOBY, VANESSA | reporter.nih.gov |
| University of Wisconsin Institute for Clinical and Translational Research | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $41,947,274 | September 21, 2017 | June 30, 2027 | BRASIER, ALLAN R. | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $41,720,565 | June 1, 1997 | November 30, 2025 | FERRIS, ROBERT L. | reporter.nih.gov |
| Regional Oncology Research Center | NIH | National Cancer Institute | 2021 to 2025 | $40,980,320 | May 7, 1997 | May 31, 2027 | NELSON, WILLIAM GEORGE | reporter.nih.gov |
| LC: HIV PREVENTION TRIALS NETWORK | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $40,489,166 | June 1, 2006 | November 30, 2027 | ESHLEMAN, SUSAN H | reporter.nih.gov |
| Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months | NIH | National Institute on Aging | 2021 to 2025 | $39,702,286 | June 1, 2020 | May 31, 2027 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| Southern California Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $39,421,921 | July 1, 2016 | March 31, 2027 | BUCHANAN, THOMAS A | reporter.nih.gov |
| UT Southwestern Center for Translational Medicine | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $39,349,638 | May 26, 2021 | April 30, 2027 | TOTO, ROBERT DANIEL | reporter.nih.gov |
| Network for Cardiothoracic Surgical Investigations in Cardiovascular Medicine | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $39,139,386 | July 1, 2007 | February 28, 2027 | GELIJNS, ANNE CHRISTINE | reporter.nih.gov |
| The Institute for Translational Medicine | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $38,399,460 | September 6, 2017 | June 30, 2027 | MELTZER, DAVID O | reporter.nih.gov |
| CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT-Moonshot Funding | NIH | National Cancer Institute | 2021 to 2025 | $38,115,589 | June 1, 2021 | May 31, 2026 | VALMONTE, CLAUDIA | reporter.nih.gov |
| Conduits: Mount Sinai Health System Translational Science Hub | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $37,137,629 | July 10, 2022 | June 30, 2027 | WRIGHT, ROSALIND J | reporter.nih.gov |
| THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE NHLBI FUNDING FROM THE WOMEN'S HEALTH INITIATIVE (WHI) - CLINICAL COORDINATING CENTER (CCC). | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $36,880,325 | February 1, 2021 | January 31, 2026 | ANDERSON, GARNET L. | reporter.nih.gov |
| University of Michigan Rogel Cancer Center Support Grant 2023-2028 | NIH | National Cancer Institute | 2021 to 2025 | $36,682,234 | June 1, 1997 | May 31, 2028 | FEARON, ERIC R. | reporter.nih.gov |
| Vanderbilt Vaccine and Treatment Evaluation Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $36,564,580 | December 11, 2019 | November 30, 2026 | CREECH, CLARENCE BUDDY | reporter.nih.gov |
| Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $36,418,175 | September 15, 2017 | August 31, 2031 | HAMADANI, MEHDI HUSSAIN | reporter.nih.gov |
| Mayo Clinic Center for Clinical and Translational Science (CCaTS) | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $35,528,345 | September 18, 2017 | June 30, 2027 | GAROVIC, VESNA D | reporter.nih.gov |
| The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD) | NIH | National Institute on Aging | 2021 to 2025 | $35,388,433 | March 1, 2021 | May 31, 2026 | KIND, AMY J. | reporter.nih.gov |
| NICHD Maternal-Fetal Medicine Units (MFMU) Network: Data CoordinatingCenter | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $35,207,419 | April 15, 1998 | March 31, 2030 | CLIFTON, REBECCA GERSNOVIEZ | reporter.nih.gov |
| Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $35,184,139 | August 1, 2021 | July 31, 2026 | COLER, RHEA | reporter.nih.gov |
| The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $35,158,235 | February 15, 2021 | January 31, 2027 | LAH, JAMES J | reporter.nih.gov |
| Epidemiology of Diabetes Interventions and Complications (EDIC) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $35,015,476 | September 22, 2011 | June 30, 2027 | GUBITOSI-KLUG, ROSE A | reporter.nih.gov |
| Childhood Asthma in Urban Settings Clinical Research Network - Leadership Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $34,858,092 | April 12, 2021 | March 31, 2028 | JACKSON, DANIEL J | reporter.nih.gov |
| CLINICAL TRIALS MONITORING SERVICE_ Moonshot support | NIH | National Cancer Institute | 2022 to 2025 | $34,785,582 | May 1, 2022 | April 30, 2026 | ANDERSON, BARRY | reporter.nih.gov |
| SWOG NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $34,321,697 | August 1, 2014 | July 31, 2026 | BLANKE, CHARLES D. | reporter.nih.gov |
| Production of Aluminum Based Adjuvants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $34,078,534 | September 20, 2017 | December 31, 2026 | MACK, FRED | reporter.nih.gov |
| Tufts Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $34,034,065 | May 1, 2023 | April 30, 2030 | SELKER, HARRY P. | reporter.nih.gov |
| NSF Engines: Louisiana Energy Transition Engine | NSF | Regional Innovation Section | 2024 | $33,821,660 | March 1, 2024 | February 28, 2029 | Michael S Mazzola | nsf.gov |
| Pediatric Eye Disease Investigator Group Coordinating Center | NIH | National Eye Institute | 2021 to 2025 | $33,066,572 | May 1, 1997 | December 31, 2028 | KRAKER, RAYMOND | reporter.nih.gov |
| Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $33,014,143 | September 25, 2023 | April 30, 2027 | BERRY, JAMES DALE | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $32,609,322 | August 2, 2001 | June 30, 2027 | EBERLEIN, TIMOTHY J. | reporter.nih.gov |
| Harvard Clinical and Translational Science Center | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $32,472,010 | May 1, 2023 | April 30, 2030 | NADLER, LEE MARSHALL | reporter.nih.gov |
| NSF Engines: Textile Innovation Engine of North Carolina | NSF | Regional Innovation Section | 2024 | $31,976,680 | March 1, 2024 | February 28, 2029 | Anne L Wiper | nsf.gov |
| ProCAN: Psychosis Risk Outcomes Compound Assessment Network | NIH | National Institute of Mental Health | 2024 to 2025 | $31,583,752 | June 14, 2024 | May 31, 2029 | WOODS, SCOTT W | reporter.nih.gov |
| SECURE PLATFORMS SUPPORT FOR THE NATIONAL CLINICAL COHORT COLLABORATIVE (N3C) DATA ENCLAVE AND NIDAP | NIH | National Institute on Drug Abuse | 2023 to 2025 | $31,451,964 | January 31, 2025 | June 10, 2025 | reporter.nih.gov | |
| Children's Oncology Group | NIH | National Cancer Institute | 2023 to 2025 | $31,354,180 | March 1, 2023 | February 28, 2026 | ALONZO, TODD A | reporter.nih.gov |
| IPP - DRUG DEVELOPMENT SUPPORT FOR CTEP | NIH | National Cancer Institute | 2022 to 2025 | $31,120,905 | July 1, 2022 | June 30, 2026 | MILLER, LAUREN | reporter.nih.gov |
| NSF Engines: Colorado - Wyoming Climate Resilience Engine | NSF | Regional Innovation Section | 2024 | $30,513,596 | March 1, 2024 | February 28, 2029 | Mike Freeman | nsf.gov |
| Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $30,295,384 | July 15, 2022 | June 30, 2028 | GIBSON, GARY E | reporter.nih.gov |
| The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) | NIH | National Institute on Aging | 2024 to 2025 | $30,281,212 | August 15, 2024 | July 31, 2029 | BOXER, ADAM L. | reporter.nih.gov |
| NSF Engines: Piedmont Triad Regenerative Medicine Engine | NSF | Regional Innovation Section | 2024 | $30,163,581 | March 1, 2024 | February 28, 2029 | Jesse T Thornburg | nsf.gov |
| Pediatric Adolescent Virus Elimination (PAVE) Martin Delaney Collaboratory | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $30,092,882 | August 16, 2021 | April 30, 2027 | PERSAUD, DEBORAH | reporter.nih.gov |
| Michigan Institute for Clinical and Health Research (MICHR) | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $30,048,018 | March 15, 2023 | February 28, 2030 | LUMENG, JULIE C | reporter.nih.gov |
| NSF Engines: Central Florida Semiconductor Innovation Engine | NSF | Regional Innovation Section | 2024 | $29,938,673 | March 1, 2024 | February 28, 2029 | Ronald F Piccolo | nsf.gov |
| NSF Engines: Upstate New York Energy Storage Engine | NSF | Regional Innovation Section | 2024 | $29,869,465 | March 1, 2024 | February 28, 2029 | Meera Sampath | nsf.gov |
| URCC NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $29,808,213 | June 1, 2025 | July 31, 2026 | MUSTIAN, KAREN M. | reporter.nih.gov |
| Neonatal Research Network Data Coordinating Center (DCC) 2023-2028 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $29,678,342 | September 1, 2025 | March 31, 2026 | DAS, ABHIK | reporter.nih.gov |
| NSF Engines: North Dakota Advanced Agriculture Technology Engine | NSF | Regional Innovation Section | 2024 | $29,494,884 | March 1, 2024 | February 28, 2029 | Hollie J Mackey | nsf.gov |
| FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | NIH | National Cancer Institute | 2021 to 2025 | $29,487,084 | April 6, 2018 | September 15, 2026 | PORRAS, CAROLINA | reporter.nih.gov |
| Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $29,187,201 | March 28, 1997 | March 31, 2027 | SLECKMAN, BARRY P | reporter.nih.gov |
| BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $29,083,069 | August 16, 2021 | April 30, 2027 | MONTANER, LUIS J | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $28,807,695 | December 1, 1996 | March 31, 2030 | TEITELL, MICHAEL A | reporter.nih.gov |
| Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial | NIH | National Institute on Aging | 2021 to 2025 | $28,784,116 | August 15, 2019 | April 30, 2027 | BRINTON, ROBERTA EILEEN | reporter.nih.gov |
| Task V15: Development of Assays and Reagents for mpox Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $28,751,383 | September 1, 2022 | April 30, 2026 | RUDGE, THOMAS | reporter.nih.gov |
| North Carolina Translational and Clinical Sciences Institute (NC TraCS) | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $28,498,535 | April 28, 2023 | March 31, 2030 | SHAHEEN, NICHOLAS J | reporter.nih.gov |
| RhoFED CDSMC | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $28,374,518 | May 8, 2023 | April 30, 2028 | SCHMIDT, PETER N. | reporter.nih.gov |
| RhoFED AA-SCCC | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $28,163,551 | May 5, 2023 | April 30, 2028 | DAVID, GLORIA | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $28,048,179 | July 4, 1997 | June 30, 2030 | RUSTGI, ANIL K | reporter.nih.gov |
| An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with Pridopidine | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $27,895,551 | September 25, 2023 | August 31, 2027 | PAGANONI, SABRINA | reporter.nih.gov |
| Task D02: Pre-Clinical Pharmacokinetic Services | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $27,852,554 | February 25, 2019 | February 24, 2020 | MIRSALIS, JON | reporter.nih.gov |
| Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant | NIH | National Cancer Institute | 2021 to 2025 | $27,607,459 | June 1, 2025 | July 31, 2026 | ROTH, MICHAEL E. | reporter.nih.gov |
| Childhood Cancer Survivorship Study | NIH | National Cancer Institute | 2021 to 2025 | $27,522,831 | July 20, 1993 | November 30, 2026 | ARMSTRONG, GREGORY | reporter.nih.gov |
| NSF Engines: Great Lakes Water Innovation Engine | NSF | Regional Innovation Section | 2024 | $27,448,182 | March 1, 2024 | February 28, 2029 | Alaina J Harkness | nsf.gov |
| ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $27,224,161 | April 9, 2020 | March 31, 2027 | LEUNG, DONALD YM | reporter.nih.gov |
| PPDs Application for the Transplantation Statistical and Clinical Coordinating Center (T-SCCC) (U01 Clinical Trial Not Allowed) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $26,732,375 | June 12, 2023 | April 30, 2028 | SEVER, MICHELLE LYNN | reporter.nih.gov |
| Physical Rehabilitation for Older Patients with Acute HFpEF-The REHAB-HFpEF Trial | NIH | National Institute on Aging | 2022 to 2025 | $26,596,811 | August 15, 2022 | July 31, 2028 | KITZMAN, DALANE W | reporter.nih.gov |
| Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $26,536,563 | September 1, 2021 | May 31, 2028 | HOH, BRIAN LIM | reporter.nih.gov |
| A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic diseases | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $26,526,303 | September 20, 2023 | July 31, 2027 | JIANG, YONG-HUI | reporter.nih.gov |
| The Florida Node Alliance of the National Drug Abuse Clinical Trials Network (CTN-121) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $26,301,696 | March 1, 2025 | February 29, 2028 | SZAPOCZNIK, JOSE | reporter.nih.gov |
| API A4 Alzheimer's Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $26,251,396 | September 1, 2018 | November 30, 2025 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| New Horizons in the Prevention and Treatment of Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $25,961,502 | April 4, 2024 | February 28, 2031 | WOOD, ROBERT A | reporter.nih.gov |
| BPN-MCSP-HIT TO LEAD CHEMISTRY- MARTIN (NUVONURO) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $25,707,343 | December 9, 2024 | June 8, 2026 | MICHELS, PETER C | reporter.nih.gov |
| UC Davis Clinical and Translational Science Center | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $25,675,346 | July 1, 2016 | May 31, 2026 | WUN, THEODORE | reporter.nih.gov |
| Data Coordinating Center (DCC) for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (NOWS PhaCET) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $25,628,714 | September 20, 2021 | August 31, 2027 | DAS, ABHIK | reporter.nih.gov |
| US POINTER Neuroimaging Ancillary Study | NIH | National Institute on Aging | 2021 to 2025 | $24,762,483 | August 1, 2019 | March 31, 2027 | LANDAU, SUSAN M | reporter.nih.gov |
| The Clinical Genome Resource – Advancing genomic medicine through biocuration and expert assessment of genes and variants at scale | NIH | National Human Genome Research Institute | 2021 to 2025 | $24,744,938 | September 12, 2017 | June 30, 2027 | BERG, JONATHAN S | reporter.nih.gov |
| BIOLOGICAL TESTING FACILITY-REGULATORY, DATA ANALYSIS, DATABASE, AND PROJECT MANAGEMENT | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $24,519,991 | July 2, 2025 | July 1, 2027 | BURNIN, DEBRA | reporter.nih.gov |
| University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $24,477,809 | February 1, 2007 | November 30, 2027 | ERON, JOSEPH J | reporter.nih.gov |
| Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $24,418,322 | July 1, 2025 | November 30, 2025 | GANTZ, MARIE G | reporter.nih.gov |
| Metformin in Alzheimer's dementia Prevention (MAP) | NIH | National Institute on Aging | 2021 to 2025 | $24,224,790 | August 15, 2019 | April 30, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| ABCD-USA Consortium: Coordinating Center | NIH | National Institute on Drug Abuse | 2021 to 2025 | $24,150,007 | September 30, 2015 | March 31, 2027 | JERNIGAN, TERRY L. | reporter.nih.gov |
| Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | NIH | National Institute of Mental Health | 2021 to 2025 | $24,090,655 | September 8, 2020 | May 31, 2026 | NELSON, CHRISTOPHER BARNABY | reporter.nih.gov |
| CRISPR for Cure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $24,038,480 | August 16, 2021 | April 30, 2027 | KHALILI, KAMEL | reporter.nih.gov |
| Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages for Everyone's Health (CLE Health) | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $24,022,255 | August 2, 2023 | June 30, 2030 | MCCOMSEY, GRACE A | reporter.nih.gov |
| Wake Forest NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $23,707,562 | August 1, 2014 | July 31, 2026 | LESSER, GLENN J | reporter.nih.gov |
| NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $23,280,590 | August 1, 2021 | January 14, 2027 | PEKOSZ, ANDREW | reporter.nih.gov |
| Division of Microbiology and Infectious Diseases (DMID): Clinical Materials Services (CMS) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $23,170,962 | September 21, 2022 | September 20, 2026 | SCHROCK, RICHARD | reporter.nih.gov |
| University of Minnesota Clinical and Translational Science Institute (UMN CTSI) | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $23,126,699 | September 18, 2023 | July 31, 2030 | BLAZAR, BRUCE R | reporter.nih.gov |
| Colorado Clinical and Translational Sciences Institute (CCTSI) | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $23,057,922 | September 15, 2023 | July 31, 2030 | SOKOL, RONALD J. | reporter.nih.gov |
| Vaccine and Treatment Evaluation Units | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $22,981,366 | December 11, 2019 | November 30, 2026 | ROUPHAEL, NADINE GEORGES | reporter.nih.gov |
| CCSG - Administrative Supplement - ECIA | NIH | National Cancer Institute | 2021 to 2025 | $22,920,176 | September 1, 1997 | March 31, 2029 | ODUNSI, KUNLE | reporter.nih.gov |
| MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE | NIH | National Cancer Institute | 2023 to 2025 | $22,579,077 | September 22, 2025 | September 21, 2027 | reporter.nih.gov | |
| NorthStar Node of the NIDA Clinical Trials Network | NIH | National Institute on Drug Abuse | 2021 to 2025 | $22,374,119 | September 1, 2015 | February 29, 2032 | BART, GAVIN | reporter.nih.gov |
| NRG Oncology Biospecimen Bank | NIH | National Cancer Institute | 2021 to 2025 | $22,321,931 | April 22, 2015 | March 31, 2026 | SIMKO, JEFF P | reporter.nih.gov |
| SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $21,986,953 | September 2, 2022 | June 30, 2027 | WILLIAMS, WILTON B | reporter.nih.gov |
| Development of Therapeutic Products for Antibiotic Resistant Bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $21,835,693 | July 1, 2020 | August 31, 2026 | PEVEAR, DANIEL | reporter.nih.gov |
| Clinical and Translational Science Award | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $21,648,836 | September 17, 2025 | May 31, 2026 | FREED, JULIE K | reporter.nih.gov |
| UZ-UCSF CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,624,239 | September 9, 2025 | November 30, 2027 | CHIRENJE, ZVAVAHERA MIKE | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $21,571,641 | August 1, 1997 | November 30, 2027 | CARPTEN, JOHN D. | reporter.nih.gov |
| UCLA AIDS Prevention and Treatment Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,546,764 | February 1, 2007 | November 30, 2027 | LANDOVITZ, RAPHAEL J | reporter.nih.gov |
| Boston HIV CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,445,869 | January 15, 2007 | November 30, 2027 | KURITZKES, DANIEL R. | reporter.nih.gov |
| Vaccine and Treatment Evaluation Unit at Saint Louis University | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,219,564 | December 11, 2019 | November 30, 2026 | HOFT, DANIEL F. | reporter.nih.gov |
| Chemistry Services for the National Toxicology Program-Per and polyfluorinated substances (PFAS) | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $21,117,591 | July 18, 2014 | January 17, 2026 | AILLON, KRISTIN | reporter.nih.gov |
| NICEATM Support Contract: Optional Level of Effort | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $21,104,694 | May 5, 2015 | November 4, 2025 | ALLEN, DAVID | reporter.nih.gov |
| A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB) | NIH | National Institute on Aging | 2023 to 2025 | $21,072,036 | February 1, 2023 | January 31, 2026 | ALAM, JOHN | reporter.nih.gov |
| Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,007,836 | April 1, 2019 | September 30, 2026 | MARGOLICK, JOSEPH B. | reporter.nih.gov |
| International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $20,605,531 | January 1, 2014 | November 30, 2027 | ALDROVANDI, GRACE M | reporter.nih.gov |
| Frontiers Clinical and Translational Science Institute at the University of Kansas | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $20,543,509 | September 7, 2017 | June 30, 2027 | CASTRO, MARIO | reporter.nih.gov |
| Alzheimer's Prevention Initiative ADAD Colombia Trial Program | NIH | National Institute on Aging | 2024 to 2025 | $20,406,409 | September 1, 2024 | August 31, 2029 | ALEXANDER, ROBERT C | reporter.nih.gov |
| Stanford Center for Clinical and Translational Research and Education | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $20,074,946 | July 1, 2024 | June 30, 2031 | O'HARA, RUTH M | reporter.nih.gov |
| Research Infrastructure: Mid-scale RI-1 (MI:IP): Dual-Doppler 3D Mobile Ka-band Rapid-Scanning Volume Imaging Radar for Earth System Science | NSF | GEO - Core Programs | 2025 | $19,982,835 | October 1, 2025 | September 30, 2030 | Jorge L Salazar Cerreno | nsf.gov |
| Vaccine and Treatment Evaluation Units (VTEU) 24-0003 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $19,949,752 | December 11, 2019 | November 30, 2026 | EL SAHLY, HANA M | reporter.nih.gov |
| SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS IMPLEMENTATION SCIENCE NETWORK | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $19,936,404 | August 25, 2025 | August 24, 2026 | DRIVER, BARBARA | reporter.nih.gov |
| Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $19,790,656 | April 10, 2019 | September 30, 2026 | WOLINSKY, STEVEN M | reporter.nih.gov |
| Metro-Minnesota Community Oncology Research Consortium (MMCORC) | NIH | National Cancer Institute | 2021 to 2025 | $19,766,845 | August 1, 2014 | July 31, 2026 | JI, YAN | reporter.nih.gov |
| Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $19,720,676 | September 16, 2019 | September 15, 2026 | FRANKENFIELD, JILL | reporter.nih.gov |
| Chemistry Center for Combatting Antibiotic-Resistant Bacteria (CC4CARB) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $19,637,160 | February 1, 2025 | January 31, 2026 | BLOUGH, BRUCE | reporter.nih.gov |
| Research Infrastructure: Mid-Scale RI-1 (M1:IP): Expanding Science Frontiers through Continental Drilling (ESF) | NSF | GEO - Core Programs | 2026 | $19,591,048 | November 1, 2026 | October 31, 2029 | Anders J Noren | nsf.gov |
| CTSA UM1 at the University of Alabama at Birmingham | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $19,550,362 | May 1, 2024 | April 30, 2031 | GUTIERREZ, ORLANDO M | reporter.nih.gov |
| Johns Hopkins Institute for Clinical and Translational Research | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $19,350,081 | May 15, 2024 | April 30, 2031 | FORD, DANIEL ERNEST | reporter.nih.gov |
| EPPIC-Net Pain Research - Application for Clinical Trial and Related Activities (OT2) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $19,316,294 | January 1, 2021 | July 31, 2026 | FAVA, MAURIZIO | reporter.nih.gov |
| ADJUVANT COMPARISON AND CHARACTERIZATION | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $19,155,153 | September 1, 2022 | August 31, 2027 | PULENDRAN, BALI | reporter.nih.gov |
| A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,851,827 | September 25, 2020 | March 31, 2027 | HAVLIR, DIANE V | reporter.nih.gov |
| Expanding HOPE Liver Transplantation: Understanding Opportunistic Infection and Cancer Risk | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,807,472 | August 1, 2018 | August 31, 2030 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| ENACT: Translating Health Informatics Tools to Research and Clinical Decision Making | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $18,659,911 | August 1, 2022 | May 31, 2027 | REIS, STEVEN E | reporter.nih.gov |
| Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors | NIH | National Cancer Institute | 2021 to 2025 | $18,653,803 | April 1, 1999 | March 31, 2026 | ONAR-THOMAS, ARZU | reporter.nih.gov |
| The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $18,588,752 | March 1, 2025 | February 29, 2032 | WINHUSEN, T JOHN | reporter.nih.gov |
| Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,362,120 | January 10, 2007 | November 30, 2027 | GULICK, ROY M. | reporter.nih.gov |
| NCATS CLINICAL AND TRANSLATIONAL SCIENCE AWARDS (CTSA) PROGRAM: COORDINATION, COMMUNICATION AND OPERATIONS SUPPORT (CCOS) | NIH | National Institute on Drug Abuse | 2022 to 2025 | $18,278,076 | September 23, 2022 | July 31, 2025 | BOUR, STEPHAN | reporter.nih.gov |
| STORAGE AND DISTRIBUTION OF CLINICAL AGENTS | NIH | National Cancer Institute | 2023 to 2025 | $18,271,500 | February 1, 2023 | January 31, 2026 | MAHZAD, MEHRINFAR | reporter.nih.gov |
| Dynamic Cognitive Phenotypes for Prediction of Mental Health Outcomes in Serious Mental Illness | NIH | National Institute of Mental Health | 2025 | $18,270,924 | September 10, 2025 | September 9, 2029 | GERMINE, LAURA THI | reporter.nih.gov |
| ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $18,205,751 | September 19, 2022 | September 18, 2026 | SAUNDERS, KEVIN | reporter.nih.gov |
| UCSD Collaborative Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,116,542 | December 1, 2024 | November 30, 2027 | WILKIN, TIMOTHY J. | reporter.nih.gov |
| Scripps Clinical and Translational Science Hub | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $18,113,488 | May 1, 2023 | April 30, 2030 | TOPOL, ERIC JEFFREY | reporter.nih.gov |
| LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INDIVIDUAL REVIEW BOARD (CIRB) | NIH | National Cancer Institute | 2024 to 2025 | $18,014,450 | September 1, 2024 | August 31, 2026 | VALMONTE, CLAUDINE | reporter.nih.gov |
| Penn State Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $17,955,915 | September 15, 2016 | June 30, 2027 | KRASCHNEWSKI, JENNIFER L. | reporter.nih.gov |
| Heartland Cancer Research NCORP | NIH | National Cancer Institute | 2021 to 2025 | $17,817,032 | August 1, 2014 | July 31, 2026 | FALLER, BRYAN | reporter.nih.gov |
| NIAID VIROLOGY QUALITY ASSURANCE (VQA) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $17,732,468 | June 21, 2025 | June 20, 2026 | DENNY, THOMAS | reporter.nih.gov |
| Guide RNA manufacturing capabilities for platform in vivo base editing therapies for metabolic liver diseases | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $17,556,074 | August 1, 2023 | July 31, 2028 | PERANTEAU, WILLIAM H. | reporter.nih.gov |
| Northeast Node of the National Drug Abuse Treatment Clinical Trials Network | NIH | National Institute on Drug Abuse | 2021 to 2025 | $17,509,561 | March 1, 2025 | February 28, 2030 | MARSCH, LISA A. | reporter.nih.gov |
| Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $17,468,154 | July 5, 2016 | May 31, 2027 | COLLER, BARRY | reporter.nih.gov |
| Development of Therapeutic Products for Antibacterial Resistant Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $17,380,862 | September 9, 2019 | January 31, 2026 | OSCHNER, URS | reporter.nih.gov |
| Kaiser Permanente NCI National Community Oncology Research Program, NCORP | NIH | National Cancer Institute | 2021 to 2025 | $17,245,643 | August 1, 2014 | July 31, 2026 | SUGA, JENNIFER MARIE | reporter.nih.gov |
| East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $17,134,028 | June 1, 2025 | June 30, 2026 | WOOLS-KALOUSTIAN, KARA KAY | reporter.nih.gov |
| Replication Study of Off-Target Assays for Guide RNAs in CRISPR-Based Therapeutics | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $17,077,732 | December 1, 2024 | April 30, 2025 | SAHA, KRISHANU | reporter.nih.gov |
| Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) | NIH | National Institute on Aging | 2023 to 2025 | $17,039,516 | August 15, 2023 | April 30, 2028 | HARRIS, KATHLEEN MULLAN | reporter.nih.gov |
| Emory-CDC CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,972,899 | December 1, 2024 | November 30, 2027 | KELLEY, COLLEEN F | reporter.nih.gov |
| Kentucky Center for Clinical and Translational Science | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $16,949,373 | August 15, 2016 | June 30, 2027 | KERN, PHILIP A | reporter.nih.gov |
| Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,914,921 | September 16, 2019 | September 30, 2026 | BERES, WENDELL | reporter.nih.gov |
| Institute for Integration of Medicine & Science: A Partnership to Improve Health | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $16,712,975 | July 25, 2023 | June 30, 2030 | CLARK, ROBERT A | reporter.nih.gov |
| The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $16,593,003 | August 22, 2023 | July 31, 2030 | JOHNSON, JULIE A. | reporter.nih.gov |
| 1/2 Pediatric Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $16,489,352 | September 15, 2021 | August 31, 2028 | MOLER, FRANK W | reporter.nih.gov |
| Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $16,391,930 | July 1, 2025 | June 30, 2029 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Cognition & Hippocampal/Cortical Systems in Aging | NIH | National Institute on Aging | 2021 to 2025 | $16,383,227 | September 1, 1997 | March 31, 2027 | KNIERIM, JAMES J | reporter.nih.gov |
| Indiana Clinical and Translational Sciences Institute | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $16,320,212 | September 5, 2025 | June 30, 2026 | MOE, SHARON M | reporter.nih.gov |
| CTSA UM1 Program at University of Utah | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $16,275,324 | April 1, 2023 | March 31, 2030 | HESS, RACHEL | reporter.nih.gov |
| The National Dental PBRN Administrative and Resource Center | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $16,239,544 | June 7, 2019 | May 31, 2027 | GILBERT, GREGG H | reporter.nih.gov |
| Administrative Supplement: The ASCEND (Advancing Skills in Contracting and Execution for NIH-Designated Grants) Initiative | NIH | National Cancer Institute | 2021 to 2025 | $16,211,327 | April 7, 2009 | March 31, 2028 | RAMALINGAM, SURESH S | reporter.nih.gov |
| University of Pennsylvania HIV Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,198,927 | February 1, 2007 | November 30, 2027 | FRANK, IAN | reporter.nih.gov |
| Pelvic Floor Disorders Network Data Coordinating Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $16,166,829 | August 8, 2011 | June 30, 2027 | GANTZ, MARIE G | reporter.nih.gov |
| Coordination for ARDS, Pneumonia, and Sepsis supporting Training, Organization and Network Efficiency (CAPSTONE) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $16,153,090 | May 1, 2023 | April 30, 2029 | SELF, WESLEY H | reporter.nih.gov |
| Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $16,136,344 | March 15, 2014 | August 31, 2026 | BROTT, THOMAS G | reporter.nih.gov |
| Michigan Cancer Research Consortium NCORP | NIH | National Cancer Institute | 2021 to 2025 | $16,033,140 | August 1, 2014 | July 31, 2026 | AL BAGHDADI, TAREQ | reporter.nih.gov |
| SWOG Biospecimen Bank to Support NCI NCTN | NIH | National Cancer Institute | 2021 to 2025 | $16,003,256 | April 23, 2015 | March 31, 2027 | RAMIREZ MILAN, NILSA DEL CARMEN | reporter.nih.gov |
| Central Africa International Epidemiology databases to Evaluate AIDS | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,957,495 | May 1, 2025 | April 30, 2027 | YOTEBIENG, MARCEL | reporter.nih.gov |
| Brain Oxygen Optimization in Severe Traumatic Brain Injury - Phase 3 (BOOST-3) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $15,805,224 | July 1, 2018 | November 30, 2025 | BARSAN, WILLIAM G | reporter.nih.gov |
| Biology of the Hormonal Regulation of Cancer and Immuno Oncology Outcomes Research Proposal. | NIH | National Cancer Institute | 2021 to 2025 | $15,746,743 | August 1, 1997 | June 30, 2027 | COUSSENS, LISA M | reporter.nih.gov |
| Therapeutic Editing to Lower PrP in Prion Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $15,507,691 | May 17, 2023 | April 30, 2026 | VALLABH, SONIA MINIKEL | reporter.nih.gov |
| PERU Clinical Trial Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,506,525 | December 1, 2024 | November 30, 2027 | SANCHEZ, JORGE LUIS | reporter.nih.gov |
| NUCATS CTSA UM1 at Northwestern University | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $15,503,048 | September 1, 2024 | July 31, 2031 | D'AQUILA, RICHARD | reporter.nih.gov |
| Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,471,597 | September 14, 2021 | June 30, 2028 | MADSEN, JOREN C | reporter.nih.gov |
| Pancreatitis-induced initiation of early onset pancreatic cancer | NIH | National Cancer Institute | 2021 to 2025 | $15,447,190 | February 1, 2025 | January 31, 2026 | SHAW, REUBEN | reporter.nih.gov |
| Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,404,946 | May 1, 2025 | June 30, 2026 | CASTILHO, JESSICA L | reporter.nih.gov |
| Catalyzing and Harmonizing Operational Innovation for Recruitment (CHOIR) | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $15,368,227 | July 14, 2023 | August 7, 2028 | HARRIS, PAUL A. | reporter.nih.gov |
| Translational Research in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $15,323,389 | June 22, 1995 | May 31, 2029 | CHAPMAN, ANDREW | reporter.nih.gov |
| Immune signatures of vaccine responses in vulnerable populations | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,275,325 | July 12, 2010 | April 30, 2028 | MONTGOMERY, RUTH R | reporter.nih.gov |
| Early Career Cancer Clinical Investigator Award (ECIA) | NIH | National Cancer Institute | 2021 to 2025 | $15,192,711 | September 26, 2005 | August 31, 2026 | SANCHEZ, YOLANDA | reporter.nih.gov |
| NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial in patients with retinitis pigmentosa | NIH | National Eye Institute | 2022 to 2025 | $15,187,946 | March 17, 2022 | July 31, 2027 | KONG, XIANGRONG | reporter.nih.gov |
| Upstate Carolina Consortium - Community Oncology Research Program | NIH | National Cancer Institute | 2021 to 2025 | $15,178,307 | May 23, 2025 | July 31, 2026 | CURTIS, AMARINTHIA E | reporter.nih.gov |
| University of Washington Vaccine and Treatment Evaluation Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,173,751 | December 11, 2019 | November 30, 2026 | WALD, ANNA | reporter.nih.gov |
| A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $15,144,108 | September 15, 2021 | August 31, 2027 | CLARDY, STACEY LYNN | reporter.nih.gov |
| PHRU-Setshaba Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,110,381 | December 1, 2024 | November 30, 2027 | GRAY, GLENDA E | reporter.nih.gov |
| Engaging Cooperative Sites for Trial Acceleration, Trust, Innovation, and Capability (ECSTATIC) | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $15,054,272 | June 29, 2023 | April 30, 2028 | CASEY, JONATHAN DALE | reporter.nih.gov |
| NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $15,021,043 | August 1, 2025 | February 28, 2026 | DART, CLINT | reporter.nih.gov |
| The Alliance NCTN Biorepository and Biospecimen Resource | NIH | National Cancer Institute | 2021 to 2025 | $15,002,332 | May 19, 2015 | March 31, 2027 | WATSON, MARK A. | reporter.nih.gov |
| The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $14,978,926 | August 25, 2022 | July 31, 2029 | PASSMAN, ROD S | reporter.nih.gov |
| Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,843,451 | August 20, 2021 | May 31, 2028 | NAJI, ALI | reporter.nih.gov |
| BIOLOGICS IDIQ TASK ORDER- NON-GLP TOXICITY AND TOXICOKINETIC STUDIES IN RODENTS AND NON-RODENTS FOR A NOVEL, SUBCUTANEOUSLY-DOSED MODIFIED-HEPARIN DRUG | NIH | National Institute on Drug Abuse | 2022 to 2025 | $14,836,664 | September 29, 2025 | September 28, 2026 | reporter.nih.gov | |
| Development of Therapeutic Products for Antibiotic Resistant Bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $14,810,179 | July 1, 2020 | October 19, 2025 | OCHSNER, URS ARNOLD | reporter.nih.gov |
| Johns Hopkins University Trial Innovation Center | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $14,762,337 | July 5, 2023 | April 30, 2028 | HANLEY, DANIEL F | reporter.nih.gov |
| Tracking and Engaging Disconnected Long-Term Survivors of Childhood Cancer to Improve Adherence to Evidence-Based Screening Guidelines | NIH | National Cancer Institute | 2021 to 2025 | $14,573,097 | September 5, 1997 | August 31, 2026 | SWEASY, JOANN B. | reporter.nih.gov |
| Task A90: Establishment of a Model of Nipah Virus Infection for Assessment of Medical Countermeasures Efficacy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,497,049 | April 15, 2024 | September 2, 2025 | BEASLEY, DAVID | reporter.nih.gov |
| FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $14,427,244 | March 1, 2020 | December 31, 2026 | BRODERICK, JOSEPH PAUL | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $14,418,205 | July 14, 2000 | March 31, 2027 | BURKARD, MARK E | reporter.nih.gov |
| Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $14,399,999 | March 26, 2024 | February 28, 2029 | SAVIC, RADOJKA | reporter.nih.gov |
| Lung Transplant Clinical Trial Network (LT-CTN) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,392,000 | June 1, 2025 | May 31, 2028 | PALMER, SCOTT M | reporter.nih.gov |
| Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study | NIH | National Institute on Aging | 2022 to 2025 | $14,339,100 | August 15, 2022 | July 31, 2028 | DEAL, JENNIFER ANNE | reporter.nih.gov |
| University of Rochester Vaccine and Treatment Evaluation Unit (VTEU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,263,529 | December 11, 2019 | November 30, 2026 | FALSEY, ANN R | reporter.nih.gov |
| The RADAR cohort study of multilevel Influences on HIV and substance use | NIH | National Institute on Drug Abuse | 2021 to 2025 | $14,251,651 | April 15, 2014 | April 30, 2030 | MUSTANSKI, BRIAN | reporter.nih.gov |
| Stanford Mendelian Genomics Research Center | NIH | National Human Genome Research Institute | 2021 to 2025 | $14,229,424 | July 15, 2021 | April 30, 2027 | MONTGOMERY, STEPHEN | reporter.nih.gov |
| 1/2 REPRIEVE Extension for Trial Completion | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $14,219,228 | May 1, 2023 | April 30, 2027 | GRINSPOON, STEVEN K. | reporter.nih.gov |
| Kaiser Washington Vaccine and Treatment Evaluation Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,173,633 | December 11, 2019 | November 30, 2026 | JACKSON, LISA A | reporter.nih.gov |
| NIH Tetramer Core Facility for Immunologic and Infectious Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,150,571 | March 21, 2020 | March 20, 2027 | ALTMAN, JOHN | reporter.nih.gov |
| Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,042,495 | April 1, 2020 | March 31, 2027 | AYE, PYONE | reporter.nih.gov |
| UNC MACS/WIHS Combined Cohort Study Clinical Research Site | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $13,957,792 | April 1, 2019 | September 30, 2026 | FLORIS-MOORE, MICHELLE | reporter.nih.gov |
| GENCODE: comprehensive gene annotation for human and mouse | NIH | National Human Genome Research Institute | 2021 to 2025 | $13,951,939 | April 1, 2013 | July 31, 2029 | MARTIN, FERGAL JAMES | reporter.nih.gov |
| Sleep for Stroke Management And Recovery Trial (Sleep SMART) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $13,933,376 | August 15, 2018 | April 30, 2027 | BROWN, DEVIN L | reporter.nih.gov |
| NCI Community Oncology Research Program 2025 Extension Request | NIH | National Cancer Institute | 2021 to 2025 | $13,851,882 | August 1, 2014 | July 31, 2026 | IRVIN, WILLIAM J | reporter.nih.gov |
| Wisconsin NCI Community Oncology Research Program (WiNCORP) | NIH | National Cancer Institute | 2021 to 2025 | $13,851,021 | August 1, 2014 | July 31, 2026 | ONITILO, ADEDAYO A | reporter.nih.gov |
| HEAL ERN: Data Coordinating Resource Center | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $13,821,158 | September 23, 2022 | August 31, 2027 | WATT, KEVIN M | reporter.nih.gov |
| Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,765,907 | April 1, 2020 | March 31, 2027 | VILLINGER, FRANCOIS | reporter.nih.gov |
| Mouse Genome Database (MGD): A Core Knowledge Resource for Functional Characterization of the Human Genome | NIH | National Human Genome Research Institute | 2021 to 2025 | $13,759,338 | July 1, 1997 | June 30, 2026 | BULT, CAROL J | reporter.nih.gov |
| Stephenson Cancer Center - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $13,739,637 | May 1, 2018 | April 30, 2028 | MANNEL, ROBERT S. | reporter.nih.gov |
| Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $13,727,424 | September 30, 2021 | July 31, 2027 | STARRELS, JOANNA L. | reporter.nih.gov |
| Admin. Supp.: Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $13,703,967 | May 15, 2023 | April 30, 2028 | DOUDNA, JENNIFER A | reporter.nih.gov |
| University of Michigan Data Coordinating Center for the Diabetic Foot Consortium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $13,554,809 | July 1, 2019 | December 31, 2027 | SPINO, CATHERINE A | reporter.nih.gov |
| HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,518,599 | April 1, 2007 | November 30, 2027 | BEKKER, LINDA-GAIL | reporter.nih.gov |
| CURE SICKLE CELL INITIATIVE DATA STRATEGY AND DATA RESOURCES PROGRAM | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $13,440,748 | September 28, 2018 | December 31, 2026 | KRONER, BARBARA L | reporter.nih.gov |
| Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $13,418,019 | June 15, 2021 | May 31, 2027 | ALONSO, ESTELLA M. | reporter.nih.gov |
| University of Virginia Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $13,417,285 | September 16, 1997 | January 31, 2027 | LOUGHRAN, THOMAS P. | reporter.nih.gov |
| The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | NIH | National Cancer Institute | 2021 to 2025 | $13,340,451 | August 1, 2025 | July 31, 2026 | DRESCHER, CHARLES | reporter.nih.gov |
| Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,340,237 | April 10, 2020 | November 30, 2026 | MULLIGAN, MARK JOSEPH | reporter.nih.gov |
| MIND DIET AND DEMENTIA PREVENTION IN ISCHEMIC STROKE PATIENTS | NIH | National Institute on Aging | 2021 to 2025 | $13,186,351 | September 1, 2020 | May 31, 2027 | AGGARWAL, NEELUM T. | reporter.nih.gov |
| Gulf South Clinical Trials Network (Gulf South NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $13,144,481 | August 1, 2014 | July 31, 2026 | OCHOA, AUGUSTO C. | reporter.nih.gov |
| IND-enabling Studies in Support of First in Human Safety Studies of a Novel Anti-Nicotine Human Monoclonal Antibody | NIH | National Institute on Drug Abuse | 2023 to 2025 | $13,125,765 | May 1, 2023 | April 30, 2027 | KALNIK, MATTHEW W | reporter.nih.gov |
| Pitt-Ohio State Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,065,770 | February 1, 2007 | November 30, 2027 | RIDDLER, SHARON | reporter.nih.gov |
| Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3 | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $13,006,073 | September 25, 2019 | July 31, 2026 | CORCOS, DANIEL M. | reporter.nih.gov |
| Einstein-Montefiore Clinical and Translational Science Award Hub | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $13,001,820 | March 3, 2023 | February 28, 2030 | KAHN, JESSICA | reporter.nih.gov |
| HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,902,047 | September 30, 2021 | July 31, 2026 | BECKER, WILLIAM C | reporter.nih.gov |
| Vanderbilt HIV Clinical Trials Unit (CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,733,650 | February 1, 2007 | November 30, 2027 | HAAS, DAVID W | reporter.nih.gov |
| Case Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,725,521 | December 1, 2024 | November 30, 2027 | YENDEWA, GEORGE | reporter.nih.gov |
| Clinical Trial Data Processing, Analysis, and Coordination Center (CT-DPACC) for Accelerating Medicines Partnership Schizophrenia (AMP SCZ) Project | NIH | National Institute of Mental Health | 2024 to 2025 | $12,671,179 | June 17, 2024 | May 31, 2029 | SHENTON, MARTHA E. | reporter.nih.gov |
| Tailored Retention and Engagement for Effective integrated Treatment of OUD and Pain (TREETOP) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,656,947 | September 30, 2021 | July 31, 2027 | WINSTANLEY, ERIN L | reporter.nih.gov |
| A Randomized, Double-Blind, Placebo-Controlled Study of LHP588 in Subjects with P. gingivalis-Positive Alzheimer's Disease | NIH | National Institute on Aging | 2025 | $12,591,952 | August 15, 2025 | July 31, 2029 | DETKE, MICHAEL J. | reporter.nih.gov |
| CURE CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,461,433 | January 1, 2007 | November 30, 2027 | SPECTOR, STEPHEN A | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $12,342,542 | February 1, 1997 | January 31, 2027 | MESA, RUBEN A. | reporter.nih.gov |
| Wright Regional Center for Clinical and Translational Science | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $12,325,812 | May 1, 2023 | April 30, 2030 | MOELLER, FREDERICK GERARD | reporter.nih.gov |
| Columbia Collaborative HIV/AIDS Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,286,513 | February 1, 2007 | November 30, 2027 | SOBIESZCZYK, MAGDALENA ELZBIETA | reporter.nih.gov |
| Broad Institute Mendelian Genomic Research Center | NIH | National Human Genome Research Institute | 2021 to 2025 | $12,228,086 | June 1, 2021 | March 31, 2027 | O'DONNELL-LURIA, ANNE | reporter.nih.gov |
| Phase III double-blind, randomized controlled trial of suvorexant versus placebo to treat insomnia in persons with opioid use disorder | NIH | National Institute on Drug Abuse | 2024 to 2025 | $12,205,195 | May 15, 2024 | February 28, 2027 | HUHN, ANDREW S | reporter.nih.gov |
| NATIONAL CLINICAL DATA COLLABORATIVE COUNTS (NACDACC) | NIH | National Institute on Drug Abuse | 2024 to 2025 | $12,127,951 | September 30, 2024 | September 29, 2025 | MAYS, GARY | reporter.nih.gov |
| Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,115,898 | December 11, 2019 | November 30, 2026 | FRENCK, ROBERT WILSON | reporter.nih.gov |
| StrokeNet Thrombectomy Endovascular Platform (STEP) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $12,112,868 | September 1, 2022 | February 28, 2026 | ELM, JORDAN J. | reporter.nih.gov |
| University of Iowa Institute for Clinical and Translational Science | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $12,092,430 | April 1, 2023 | March 31, 2030 | WINOKUR, PATRICIA | reporter.nih.gov |
| Center for Research and Education on Aging and Technology Enhancement - CREATE | NIH | National Institute on Aging | 2022 to 2025 | $12,069,399 | June 15, 2022 | May 31, 2027 | CZAJA, SARA J | reporter.nih.gov |
| Nutrition for Precision Health: The University of North Carolina at Chapel Hill Clinical Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $12,065,421 | December 10, 2021 | November 30, 2026 | MAYER-DAVIS, ELIZABETH J | reporter.nih.gov |
| A Safety and Efficacy Study of AAV2-hAADC for AADC Deficiency | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $12,060,518 | September 15, 2016 | August 31, 2027 | BANKIEWICZ, KRYSTOF S | reporter.nih.gov |
| Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trial | NIH | National Institute on Aging | 2021 to 2025 | $12,029,156 | January 1, 2021 | December 31, 2026 | KHOSLA, SUNDEEP | reporter.nih.gov |
| Center for Live Cell Genomics | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,992,289 | September 15, 2021 | June 30, 2027 | HAUSSLER, DAVID H | reporter.nih.gov |
| Miami Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $11,973,000 | August 18, 2023 | June 30, 2030 | CARRASQUILLO, OLVEEN | reporter.nih.gov |
| A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,962,900 | September 30, 2021 | July 31, 2027 | LUCIANO, MARK GREGORY | reporter.nih.gov |
| Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | NIH | National Institute on Drug Abuse | 2023 to 2025 | $11,962,715 | August 15, 2023 | June 30, 2026 | LI, XINHUA | reporter.nih.gov |
| Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (SEA-NOBI-ALS) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $11,846,278 | September 1, 2024 | August 31, 2028 | OSKARSSON, BJORN E | reporter.nih.gov |
| (EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank | NIH | National Cancer Institute | 2021 to 2025 | $11,843,510 | September 1, 2020 | March 31, 2027 | NICOL, KATHLEEN | reporter.nih.gov |
| Targeting the B Cell Response to Treat Antibody-Mediated Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,789,092 | August 20, 2021 | May 31, 2028 | KNECHTLE, STUART JOHNSTON | reporter.nih.gov |
| Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) - Indiana University Data Coordinating Center | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $11,773,646 | August 1, 2018 | June 30, 2029 | TU, WANZHU | reporter.nih.gov |
| REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD | NIH | National Institute on Aging | 2024 to 2025 | $11,773,020 | January 1, 2024 | December 31, 2028 | ELY, E WESLEY | reporter.nih.gov |
| DEVELOPMENT OF THERAPEUTIC PRODUCTS FOR ENTEROVIRUSES | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,757,152 | September 1, 2020 | May 31, 2030 | GLENN, JEFFREY | reporter.nih.gov |
| Baylor College of Medicine - Mendelian Genomics Research Center (BCM-MGRC) | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,728,929 | July 15, 2021 | April 30, 2027 | GIBBS, RICHARD A | reporter.nih.gov |
| Medical University of South Carolina - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $11,675,386 | April 1, 2009 | March 31, 2029 | DUBOIS, RAYMOND N. | reporter.nih.gov |
| UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $11,668,134 | September 1, 2022 | August 31, 2027 | LEIN, PAMELA J | reporter.nih.gov |
| NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,660,249 | July 15, 2020 | October 31, 2025 | PHILLIPS, ELIZABETH | reporter.nih.gov |
| Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS). | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $11,639,047 | September 25, 2023 | August 31, 2027 | ANDREWS, JINSY | reporter.nih.gov |
| Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $11,597,222 | December 1, 2024 | November 30, 2025 | DENNY, TOM | reporter.nih.gov |
| Consortium for Translational and Precision Health | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $11,411,362 | September 1, 2024 | July 31, 2031 | KANWAL, FASIHA | reporter.nih.gov |
| Cancer Research Consortium of West Michigan (CRCWM) | NIH | National Cancer Institute | 2021 to 2025 | $11,366,311 | August 8, 2014 | July 31, 2026 | BUTLER, KATHLEEN YOST | reporter.nih.gov |
| KwaZulu-Natal Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,302,268 | December 1, 2024 | November 30, 2027 | ABDOOL KARIM, QUARRAISHA | reporter.nih.gov |
| Advancing Transplantation Outcomes in Children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,293,854 | July 1, 2025 | June 30, 2028 | BRISCOE, DAVID M. | reporter.nih.gov |
| Clinical Development of COVID-19 Therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $11,286,393 | September 22, 2023 | February 15, 2026 | WANG, STANLEY | reporter.nih.gov |
| Pre-Symptomatic Familial ALS (Pre-fALS) Study: From Prodrome and Biomarkers to ALS/FTD Prevention | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $11,282,768 | September 15, 2018 | July 31, 2029 | BENATAR, MICHAEL | reporter.nih.gov |
| A Global Map of Interactions Among Human Cell Surface Proteins and Secreted Ligands | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $11,281,013 | September 30, 2022 | August 31, 2027 | ZINN, KAI G | reporter.nih.gov |
| NJ ACTS: A Platform for Translational Science in New Jersey | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $11,270,857 | May 1, 2024 | April 30, 2031 | PANETTIERI, REYNOLD ALEXANDER | reporter.nih.gov |
| Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,268,155 | September 1, 2020 | March 31, 2027 | MALINOWSKI, FRANK | reporter.nih.gov |
| The Johns Hopkins University-Blantyre Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,246,510 | February 15, 2007 | November 30, 2027 | TAHA, TAHA E | reporter.nih.gov |
| California Partnership for Personalized Nutrition | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $11,224,088 | December 10, 2021 | November 30, 2026 | ADAMS, SEAN HARRISON | reporter.nih.gov |
| Carle Cancer Center NCI Community Oncology Research Program (NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $11,214,272 | August 8, 2014 | July 31, 2026 | ROWLAND, KENDRITH MARTIN | reporter.nih.gov |
| Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,202,199 | March 15, 2007 | September 21, 2025 | SANNE, IAN MATTHIAS | reporter.nih.gov |
| Site-Directed RNA Editing of Nav1.7 as a Novel Analgesic | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,194,636 | September 23, 2021 | August 31, 2027 | ROSENTHAL, JOSHUA J.C. | reporter.nih.gov |
| Center for Clinical and Translational Sciences | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $11,187,532 | July 24, 2024 | June 30, 2031 | MCPHERSON, DAVID D | reporter.nih.gov |
| From Nerve to Brain: Toward a Mechanistic Understanding of Spinal Cord Stimulation in Human Subjects | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $11,100,837 | September 22, 2022 | August 31, 2027 | WAINGER, BRIAN JASON | reporter.nih.gov |
| Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,947,708 | February 5, 2007 | November 30, 2027 | GUPTA, AMITA | reporter.nih.gov |
| Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,920,671 | September 6, 2021 | June 30, 2028 | BOIKE, JUSTIN | reporter.nih.gov |
| Advanced Development of a Universal Influenza Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,853,574 | September 9, 2019 | April 24, 2025 | LOCHER, CHRISTOPHER | reporter.nih.gov |
| Longitudinal Imaging Biomarkers of Prodromal DLB | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,821,041 | September 25, 2017 | August 31, 2027 | KANTARCI, KEJAL | reporter.nih.gov |
| Innervation of the knee and TMJ | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $10,814,779 | September 23, 2022 | August 31, 2027 | ALLEN, KYLE D | reporter.nih.gov |
| Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium | NIH | National Cancer Institute | 2021 to 2025 | $10,811,170 | August 23, 2019 | July 31, 2026 | JASLOWSKI, ANTHONY J | reporter.nih.gov |
| AIDS Clinical Trials Group (ACTG) DMC Activities | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,797,892 | December 1, 2020 | November 30, 2027 | MAGNUS, MANYA | reporter.nih.gov |
| Increasing the Efficiency of RE-JOIN Through Data Sharing and Integration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $10,788,004 | September 23, 2022 | July 31, 2027 | LEE, BRENDAN | reporter.nih.gov |
| Liver Cirrhosis Network: Scientific and Data Coordination Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $10,655,826 | August 28, 2021 | July 31, 2027 | SMITH, ABIGAIL | reporter.nih.gov |
| Greater Intermountain Node (CTN-0138) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,595,733 | March 1, 2025 | February 29, 2032 | COCHRAN, GERALD T. | reporter.nih.gov |
| Arterial Stiffness, Cognition, and Equol (ACE) | NIH | National Institute on Aging | 2022 to 2025 | $10,581,052 | February 15, 2022 | January 31, 2027 | SEKIKAWA, AKIRA | reporter.nih.gov |
| Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,550,278 | September 30, 2020 | July 31, 2026 | SPRINGER, SANDRA ANN | reporter.nih.gov |
| Administrative Supplement Request for 2025 Systems Biology for Infectious Diseases Annual Meeting | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,511,156 | August 17, 2018 | May 31, 2028 | KROGAN, NEVAN J | reporter.nih.gov |
| NSF Critical Mineral Accelerator Engine in Alaska | NSF | Regional Innovation Section | 2026 | $10,500,000 | August 1, 2026 | July 31, 2036 | Lee A Munk | nsf.gov |
| VCID Biomarkers Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $10,493,954 | September 30, 2016 | June 30, 2027 | GREENBERG, STEVEN M | reporter.nih.gov |
| Integrative Treatment for Achieving Holistic Recovery from Comorbid Chronic Pain and Opioid Use Disorder | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,475,915 | September 30, 2021 | July 31, 2027 | WITKIEWITZ, KATIE A | reporter.nih.gov |
| ICAP Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,475,165 | December 1, 2020 | November 30, 2027 | EL-SADR, WAFAA M. | reporter.nih.gov |
| National Dental Practice-Based Research Network: Coordinating Center | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $10,434,648 | June 7, 2019 | May 31, 2027 | MCMULLEN, CARMIT KURN | reporter.nih.gov |
| MSK SPORE in Genomic Instability in Breast Cancer | NIH | National Cancer Institute | 2021 to 2025 | $10,402,609 | August 13, 2020 | July 31, 2026 | POWELL, SIMON N. | reporter.nih.gov |
| NIH StrokeNet National Clinical Coordinating Center (NCC) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,366,158 | September 30, 2013 | November 30, 2028 | BRODERICK, JOSEPH PAUL | reporter.nih.gov |
| CTSA UM1 Program at University of California San Diego Altman Clinical and Translational Research Institute | NIH | National Center for Advancing Translational Sciences | 2025 | $10,325,540 | August 1, 2025 | April 30, 2032 | SMITH, DAVID MITCHELL | reporter.nih.gov |
| Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA. | NIH | National Institute on Aging | 2022 to 2025 | $10,320,460 | February 15, 2022 | January 31, 2027 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| Validation of Early Prognostic Data for Recovery Outcomes after Stroke for Future, Higher Yield Trials (VERIFY) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,302,336 | September 1, 2021 | July 1, 2025 | KHATRI, POOJA | reporter.nih.gov |
| NIH Health Care Systems Research Collaboratory-Coordinating Center (U24) | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $10,249,994 | September 22, 2022 | May 31, 2028 | HERNANDEZ, ADRIAN | reporter.nih.gov |
| Nutrition Precision Health for All of Us (Chicago Center) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $10,228,129 | December 10, 2021 | November 30, 2026 | VAN HORN, LINDA VERNER | reporter.nih.gov |
| University of Rochester HIV/AIDS Clinical Trials Unit Administrative Supplement | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,156,163 | August 26, 2025 | November 30, 2027 | KEEFER, MICHAEL C | reporter.nih.gov |
| The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study | NIH | National Cancer Institute | 2021 to 2025 | $10,080,862 | June 23, 2015 | March 31, 2026 | CERHAN, JAMES R | reporter.nih.gov |
| The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial EXTENDed Follow-up (EXTEND) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $10,079,314 | April 1, 2021 | March 31, 2027 | HOCHMAN, JUDITH S | reporter.nih.gov |
| Colorado Head and Neck Cancer SPORE | NIH | National Cancer Institute | 2021 to 2025 | $10,073,085 | September 1, 2021 | August 31, 2026 | JIMENO, ANTONIO | reporter.nih.gov |
| Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,070,868 | March 15, 2007 | November 30, 2027 | SUPPARATPINYO, KHUANCHAI | reporter.nih.gov |
| Rat Genome Database | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $10,063,966 | September 30, 1999 | December 31, 2026 | KWITEK, ANNE E. | reporter.nih.gov |
| StATins Use in intRacerebral hemorrhage patieNts (SATURN) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,035,219 | September 1, 2019 | February 29, 2028 | SELIM, MAGDY H | reporter.nih.gov |
| NHLBI CATALYZE PRECLINICAL SERVICES: PROJECTS YR. 4 - TASK ORDER 5 | NIH | National Heart, Lung, and Blood Institute | 2025 | $9,999,898 | September 29, 2025 | September 28, 2026 | JONES, HENDREE E | reporter.nih.gov |
| Advanced Development of a Multivalent Vaccine Candidate for Lassa Fever | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,931,387 | September 1, 2017 | January 31, 2027 | SCHNELL, MATTHIAS JOHANNES | reporter.nih.gov |
| The Pacific Northwest Prostate Cancer SPORE | NIH | National Cancer Institute | 2021 to 2025 | $9,924,776 | September 19, 2002 | August 31, 2028 | NELSON, PETER S | reporter.nih.gov |
| NHLBI CATALYZE COORDINATING CENTER SUPPORT SERVICES | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $9,914,295 | September 25, 2023 | September 24, 2026 | SEVERYNSE-STEVENS, DIANA | reporter.nih.gov |
| The Military HIV Research Program (MHRP) Clinical Trial Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,910,676 | December 10, 2013 | November 30, 2027 | ROBB, MERLIN L | reporter.nih.gov |
| The Johns Hopkins University - Uganda Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,910,249 | February 5, 2007 | November 30, 2027 | FOWLER, MARY GLENN | reporter.nih.gov |
| CTSA UM1 at Duke University | NIH | National Center for Advancing Translational Sciences | 2025 | $9,890,205 | August 15, 2025 | July 31, 2032 | NAGGIE, SUSANNA | reporter.nih.gov |
| PF614-MPAR: clinical development of opioid with oral overdose protection | NIH | National Institute on Drug Abuse | 2024 to 2025 | $9,861,616 | September 1, 2024 | May 31, 2027 | KIRKPATRICK, LYNN | reporter.nih.gov |
| Georgia NCI Community Oncology Research Program (GA NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $9,828,045 | August 9, 2014 | July 31, 2026 | CANTUARIA, GUILHERME | reporter.nih.gov |
| Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,824,534 | February 1, 2007 | June 30, 2025 | LOCKMAN, SHAHIN | reporter.nih.gov |
| Silence ALS: A Platform for the Discovery and Development of Antisense Therapeutics for Patients with Ultra-Rare Forms of ALS | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $9,796,602 | March 1, 2024 | February 28, 2027 | SHNEIDER, NEIL ALAN | reporter.nih.gov |
| Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $9,739,425 | September 1, 2022 | April 30, 2027 | GLADWIN, MARK T | reporter.nih.gov |
| Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,737,772 | June 1, 2021 | May 31, 2027 | MORRELL, MARTHA J | reporter.nih.gov |
| Select Late-Stage CMC, Non-clinical Studies, and Quality Programs to Accelerate NRS-033 Towards Pivotal Studies and Registration in Opioid Use Disorder | NIH | National Institute on Drug Abuse | 2024 to 2025 | $9,732,775 | August 1, 2024 | May 31, 2027 | SHAH, NIKEJ | reporter.nih.gov |
| GHESKIO Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,655,243 | February 1, 2007 | November 30, 2027 | PAPE, JEAN WILLIAM | reporter.nih.gov |
| Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,632,234 | September 28, 2015 | June 30, 2030 | LI, LIANG | reporter.nih.gov |
| Aurora NCORP Community Site | NIH | National Cancer Institute | 2021 to 2025 | $9,617,195 | August 15, 2014 | July 31, 2026 | SAPHNER, THOMAS J | reporter.nih.gov |
| Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Blocker Discovery | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $9,584,357 | September 30, 2025 | September 29, 2026 | SILVERA, PETER | reporter.nih.gov |
| Southern Consortium Node of the Clinical Trials Network (TMS for CUD) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,579,585 | March 1, 2025 | February 29, 2032 | BARTH, KELLY S. | reporter.nih.gov |
| Task B1: Phase I Clinical Trial to Evaluate a Therapeutic for Antibiotic Resistant Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,576,633 | May 13, 2021 | January 31, 2025 | BURMAN, BRIDGETT | reporter.nih.gov |
| DEVELOPMENT OF UM-1098: A NOVEL SYNTHETIC TH17 INDUCING ADJUVANT AND DELIVERY SYSTEM | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $9,566,206 | September 30, 2023 | September 29, 2026 | EVANS, JAY | reporter.nih.gov |
| Tissue destruction and healing in Celiac Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $9,512,977 | September 15, 2022 | July 31, 2027 | JABRI, BANA | reporter.nih.gov |
| CI CoE: SGX3 - A Center of Excellence to Extend Access, Expand the Community, and Exemplify Good Practices for CI Through Science Gateways | NSF | Office of Advanced Cyberinfrastructure | 2022 | $9,511,691 | September 1, 2022 | August 31, 2027 | Sandra Gesing | nsf.gov |
| Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid and Tau in Older Adults (IPAT-study) | NIH | National Institute on Aging | 2022 to 2025 | $9,488,371 | August 1, 2022 | July 31, 2027 | ZHANG, RONG | reporter.nih.gov |
| Thin, High-Density, High-Performance, Depth and Surface Microelectrodes for Diagnosis and Treatment of Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,482,559 | September 1, 2021 | August 31, 2027 | DAYEH, SHADI | reporter.nih.gov |
| BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial | NIH | National Institute on Aging | 2021 to 2025 | $9,481,336 | February 15, 2021 | November 30, 2026 | HANLEY, DANIEL F | reporter.nih.gov |
| Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) | NIH | National Institute on Aging | 2025 | $9,466,491 | September 1, 2023 | August 31, 2028 | STONE, KATIE L | reporter.nih.gov |
| Clinical Trial Advancement and Development for Sarcomas | NIH | National Cancer Institute | 2022 to 2025 | $9,446,195 | September 11, 1997 | January 31, 2027 | VAN ETTEN, RICHARD A. | reporter.nih.gov |
| Predicting and Understanding the Use of Nicotine Products In a Rapidly Evolving Nicotine Marketplace: The International Nicotine Product, Policy, and Market (INPAM) Study | NIH | National Cancer Institute | 2021 to 2025 | $9,428,812 | April 19, 2016 | August 31, 2026 | CUMMINGS, KENNETH MICHAEL | reporter.nih.gov |
| Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,418,230 | September 1, 2021 | August 31, 2026 | GOATE, ALISON M | reporter.nih.gov |
| Childhood Liver Disease Research Network (ChiLDReN) Scientific and Data Coordinating Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,404,513 | September 18, 2002 | May 31, 2029 | MAGEE, JOHN C | reporter.nih.gov |
| University of Michigan Multi-disciplinary Coordinating Center for the Community Firearm Injury Prevention Network | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $9,371,829 | September 15, 2022 | August 31, 2027 | CARTER, PATRICK M. | reporter.nih.gov |
| Nonhuman Primate Reagent Resource | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,318,044 | September 29, 2016 | March 31, 2027 | MAGNANI, DIOGO | reporter.nih.gov |
| Ketamine Add-On for Established Status Epilepticus Treatment Trial (KESETT) | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $9,296,510 | January 15, 2025 | December 31, 2026 | KAPUR, JAIDEEP | reporter.nih.gov |
| Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study | NIH | National Cancer Institute | 2021 to 2025 | $9,251,154 | September 19, 2016 | August 31, 2026 | ULRICH, CORNELIA M | reporter.nih.gov |
| Development of a Novel Therapeutic for Melioidosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $9,235,577 | September 20, 2022 | September 30, 2026 | ALLEY, M.R.K. (DICKON) | reporter.nih.gov |
| An Encyclopedia of the Adipose Tissue Secretome to Identify Mediators of Health and Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,233,323 | July 15, 2021 | June 30, 2026 | COHEN, PAUL | reporter.nih.gov |
| Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $9,218,182 | August 24, 2022 | July 31, 2027 | BARKER, BRIDGET MARIE | reporter.nih.gov |
| Institutional Career Development Core | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $9,212,815 | July 18, 2016 | June 30, 2026 | SARKAR, URMIMALA | reporter.nih.gov |
| COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,161,352 | September 15, 2019 | August 31, 2029 | MARTIN, MARTIN G | reporter.nih.gov |
| Global Network for Women's and Children's Health Research Data Coordinating Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $9,151,864 | July 1, 2017 | June 30, 2030 | MCCLURE, ELIZABETH M | reporter.nih.gov |
| Translational Research in Breast Cancer | NIH | National Cancer Institute | 2021 to 2025 | $9,097,808 | September 19, 2014 | July 31, 2026 | ZHANG, XIANG | reporter.nih.gov |
| American Women: Assessing Risk Epidemiologically (AWARE - RFA) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $9,079,530 | August 18, 2022 | July 31, 2028 | SCHNALL, REBECCA | reporter.nih.gov |
| MoTrPAC DXA Quality Control | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $9,075,021 | September 15, 2025 | August 31, 2026 | KRAUS, WILLIAM E | reporter.nih.gov |
| Resilience and brain health of older adults | NIH | National Institute on Aging | 2021 to 2025 | $9,066,206 | August 15, 2021 | May 31, 2027 | LENZE, ERIC J | reporter.nih.gov |
| Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers | NIH | National Institute on Drug Abuse | 2023 to 2025 | $9,048,057 | September 30, 2023 | August 31, 2026 | COSFORD, NICHOLAS DAVID | reporter.nih.gov |
| Digital, Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,011,446 | March 9, 2021 | February 28, 2027 | MIMIAGA, MATTHEW JAMES | reporter.nih.gov |
| A-Z Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,989,738 | February 1, 2007 | November 30, 2027 | GOEPFERT, PAUL A. | reporter.nih.gov |
| A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials | NIH | National Cancer Institute | 2021 to 2025 | $8,980,562 | March 7, 2019 | February 28, 2026 | FURQAN, MUHAMMAD | reporter.nih.gov |
| Interventions That Retard Mammalian Aging | NIH | National Institute on Aging | 2021 to 2025 | $8,876,368 | April 15, 2003 | May 31, 2029 | KORSTANJE, RONNY | reporter.nih.gov |
| Translational Platform for Epilepsy Therapy and Biomarker Discovery | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $8,833,081 | April 15, 2022 | March 31, 2027 | GALANOPOULOU, ARISTEA S | reporter.nih.gov |
| UAB Precision Nutrition Clinical Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $8,773,942 | December 10, 2021 | November 30, 2026 | HILL, JAMES O | reporter.nih.gov |
| Delaware Christiana Care NCORP | NIH | National Cancer Institute | 2021 to 2025 | $8,723,018 | August 1, 2014 | July 31, 2026 | MASTERS, GREGORY A | reporter.nih.gov |
| Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum Administrative Supplement | NIH | National Cancer Institute | 2021 to 2025 | $8,668,837 | September 1, 2020 | August 31, 2026 | TRENTHAM-DIETZ, AMY | reporter.nih.gov |
| Data Coordinating Center for the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Continuation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $8,663,508 | May 1, 2002 | June 30, 2028 | SHADE, DAVID M | reporter.nih.gov |
| AMETHIST@Penn: Achieving Maternal Empowerment and Transforming Health through Implementation Science and Training | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $8,629,719 | August 15, 2023 | July 31, 2030 | HAMM, REBECCA FELDMAN | reporter.nih.gov |
| The University of Kansas Cancer Center's- MCA Rural NCORP- extension | NIH | National Cancer Institute | 2021 to 2025 | $8,620,990 | August 13, 2019 | July 31, 2026 | DOOLITTLE, GARY C. | reporter.nih.gov |
| Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,604,388 | May 1, 2021 | April 30, 2027 | CAHILL, KATHERINE N | reporter.nih.gov |
| NCATS SCIENTIFIC AND TECHNOLOGY SUPPORT SERVICES (STSS) | NIH | National Institute on Drug Abuse | 2024 to 2025 | $8,491,687 | September 30, 2024 | January 6, 2025 | MAYS, GARY | reporter.nih.gov |
| Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $8,481,225 | September 1, 2022 | August 31, 2027 | AMIN, RAOUF S. | reporter.nih.gov |
| Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man | NIH | National Institute on Drug Abuse | 2024 to 2025 | $8,480,887 | September 30, 2019 | April 30, 2027 | GRIGSON, PATRICIA SUE | reporter.nih.gov |
| Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,478,988 | April 1, 2020 | March 31, 2027 | LEWIS, MARK | reporter.nih.gov |
| Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,451,589 | September 17, 2021 | August 31, 2027 | FREEDMAN, STEPHEN BRADLEY | reporter.nih.gov |
| Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn's Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $8,401,766 | April 1, 2023 | March 31, 2028 | HYAMS, JEFFREY SAMUEL | reporter.nih.gov |
| Sources, Transport, Exposure & Effects of PFAS (STEEP) Center - RENEWAL | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $8,380,014 | September 1, 2017 | June 30, 2027 | LOHMANN, RAINER | reporter.nih.gov |
| Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models | NIH | National Institute on Aging | 2021 to 2025 | $8,376,812 | July 1, 2021 | June 30, 2026 | SHULMAN, JOSHUA M | reporter.nih.gov |
| Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $8,348,817 | September 15, 2022 | May 31, 2027 | ALBER, JESSICA | reporter.nih.gov |
| Central Hub for Kidney Precision Medicine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $8,320,420 | July 1, 2024 | June 30, 2027 | HIMMELFARB, JONATHAN | reporter.nih.gov |
| San Francisco Bay Clinical Trials Unit (CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,314,128 | March 2, 2007 | November 30, 2027 | BUCHBINDER, SUSAN | reporter.nih.gov |
| Immunotherapy for Ocular Surface Diseases | NIH | National Eye Institute | 2021 to 2025 | $8,312,140 | February 1, 2021 | December 31, 2026 | JAIN, SANDEEP | reporter.nih.gov |
| A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $8,293,749 | September 30, 2021 | August 31, 2026 | ZAIDI, MONE | reporter.nih.gov |
| Washington University Intellectual and Developmental Disabilities Research Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $8,281,463 | July 28, 2020 | May 31, 2027 | DOUGHERTY, JOSEPH D | reporter.nih.gov |
| The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,239,326 | January 15, 2008 | November 30, 2027 | GRINSZTEJN, BEATRIZ | reporter.nih.gov |
| Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $8,189,971 | September 15, 2024 | August 31, 2026 | GITLER, AARON D. | reporter.nih.gov |
| A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $8,184,774 | May 15, 2022 | April 30, 2027 | WANI, SACHIN | reporter.nih.gov |
| Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone? | NIH | National Institute on Drug Abuse | 2023 to 2025 | $8,178,365 | September 30, 2019 | August 31, 2026 | KAMPMAN, KYLE MATTHEW | reporter.nih.gov |
| Emergency General Surgery Delirium Recovery Model: A Collaborative Care Intervention | NIH | National Institute on Aging | 2022 to 2025 | $8,173,947 | July 1, 2022 | June 30, 2027 | ZARZAUR, BEN L | reporter.nih.gov |
| Institute for Clinical and Translational Science | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $8,164,968 | July 16, 2024 | June 30, 2031 | VILAIN, ERIC J. | reporter.nih.gov |
| Dartmouth Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $8,141,832 | July 25, 2024 | June 30, 2031 | BERNSTEIN, STEVEN L | reporter.nih.gov |
| The NCI Community Oncology Research Program: The New Mexico NCORP | NIH | National Cancer Institute | 2021 to 2025 | $8,085,672 | August 9, 2014 | July 31, 2026 | MULLER, CAROLYN Y. | reporter.nih.gov |
| cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $8,013,603 | August 30, 2022 | August 29, 2030 | HASSELL, THOMAS | reporter.nih.gov |
| Comprehensive functional phenotyping of trigeminal neurons innervating temporomandibular joint (TMJ) tissues in male female and aged mice primates and humans with and without TMJ disorders (TMJD) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $8,002,252 | September 23, 2022 | August 31, 2027 | AKOPIAN, ARMEN N | reporter.nih.gov |
| Genomic risk in clinical care to promote preventive health in New York City patients | NIH | National Human Genome Research Institute | 2021 to 2025 | $7,984,720 | July 1, 2020 | April 30, 2027 | KENNY, EIMEAR ELIZABETH | reporter.nih.gov |
| CTSA UM1 Program at Wake Forest | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $7,981,899 | July 1, 2024 | June 30, 2031 | HOUSTON, THOMAS K | reporter.nih.gov |
| THE NIH PRECISION BRAIN HEALTH NETWORK: Open and Inclusive Measurement of Neuropsychological Change for AD/ADRD Primary Prevention Trials | NIH | National Institute on Aging | 2025 | $7,948,867 | August 1, 2025 | July 31, 2030 | SLIWINSKI, MARTIN J | reporter.nih.gov |
| Development of SBS-226, a MOR agonist / DOR antagonist, for OUD | NIH | National Institute on Drug Abuse | 2024 to 2025 | $7,941,988 | September 30, 2024 | August 31, 2027 | REICH, JEFFREY | reporter.nih.gov |
| Phosphate binder therapy and chronic kidney disease in children | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,929,421 | June 15, 2020 | April 30, 2026 | SALUSKY, ISIDRO B. | reporter.nih.gov |
| SUPPORT SERVICES FOR THE CTEP PHARMACEUTICAL MANAGEMENT BRANCH (PMB) | NIH | National Cancer Institute | 2022 to 2025 | $7,922,356 | September 1, 2022 | August 31, 2026 | GRAY, ARIE | reporter.nih.gov |
| RACE-CARS CCC 1/2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,922,259 | July 1, 2020 | June 30, 2027 | GRANGER, CHRISTOPHER B. | reporter.nih.gov |
| Expanding Translational Science in Arkansas | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $7,916,776 | July 1, 2024 | June 30, 2031 | JAMES, LAURA P | reporter.nih.gov |
| External Quality Assurance Program Oversight Laboratory (EQAPOL) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $7,902,910 | September 30, 2024 | September 29, 2031 | DENNY, THOMAS | reporter.nih.gov |
| Communication Bridge: Optimizing an evidence-based intervention for individuals with primary progressive aphasia | NIH | National Institute on Aging | 2023 to 2025 | $7,878,167 | September 15, 2017 | August 31, 2028 | ROGALSKI, EMILY J | reporter.nih.gov |
| Development of the novel mu-opioid receptor antagonist methocinnamox (MCAM) for preventing relapse and overdose | NIH | National Institute on Drug Abuse | 2024 to 2025 | $7,874,666 | August 15, 2024 | December 31, 2027 | FRANCE, CHARLES P | reporter.nih.gov |
| Restoring Vision with High-Fidelity Nonsense Codon Correction | NIH | National Eye Institute | 2021 to 2025 | $7,812,597 | February 1, 2021 | November 30, 2026 | PATTNAIK, BIKASH RANJAN | reporter.nih.gov |
| Greater Southern California Node of the Clinical Trials Network | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,788,993 | June 1, 2019 | February 29, 2032 | MOONEY, LARISSA JEANETTE | reporter.nih.gov |
| The Osteoarthritis Prevention Study (TOPS) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $7,779,027 | August 10, 2023 | July 31, 2028 | MESSIER, STEPHEN P | reporter.nih.gov |
| A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients (THINKER-NEXT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,767,541 | April 15, 2021 | March 31, 2027 | SCHAUBEL, DOUGLAS EARL | reporter.nih.gov |
| Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2025 | $7,757,977 | July 1, 2021 | June 30, 2027 | KAYED, RAKEZ | reporter.nih.gov |
| Comparing Treatment Approaches to Promote Inpatient Rehabilitation Effectiveness for Traumatic Brain Injury (CARE 4 TBI) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $7,746,716 | September 15, 2021 | August 31, 2028 | BOGNER, JENNIFER A | reporter.nih.gov |
| NCATS SCIENTIFIC AND TECHNOLOGY PROGRAM SUPPORT (STPS) | NIH | National Institute on Drug Abuse | 2025 | $7,700,000 | February 18, 2025 | September 27, 2025 | reporter.nih.gov | |
| Seattle Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $7,698,581 | February 1, 2007 | November 30, 2027 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome | NIH | National Cancer Institute | 2022 to 2025 | $7,696,898 | September 20, 2022 | August 31, 2027 | GRADY, WILLIAM MALLORY | reporter.nih.gov |
| COMPASS: A comprehensive mobile precision approach for scalable solutions in mental health treatment | NIH | National Institute of Mental Health | 2024 to 2025 | $7,663,794 | July 1, 2024 | April 30, 2026 | BOHNERT, AMY S B | reporter.nih.gov |
| I. Institutional Career Development Core | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $7,643,843 | September 5, 2017 | June 30, 2027 | ZHU, YUAN-SHAN | reporter.nih.gov |
| A biochemical roadmap of exercise signal | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,628,641 | June 1, 2025 | May 31, 2027 | GERSZTEN, ROBERT E | reporter.nih.gov |
| Center for Testing Potential Anti-Aging Interventions | NIH | National Institute on Aging | 2021 to 2025 | $7,623,448 | April 15, 2004 | May 31, 2029 | SALMON, ADAM | reporter.nih.gov |
| Early Phase Clinical Cancer Prevention Consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,613,555 | July 7, 2020 | July 31, 2031 | SCHUETZE, SCOTT MICHAEL | reporter.nih.gov |
| Institutional Career Development Core | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $7,606,580 | September 18, 2017 | June 30, 2027 | ERTEKIN-TANER, NILUFER | reporter.nih.gov |
| Look AHEAD Sleep: Sleep-disordered breathing, circadian rest/activity rhythms, and the risk of Alzheimer's disease and related dementias in Look AHEAD | NIH | National Institute on Aging | 2021 to 2025 | $7,592,411 | August 15, 2021 | May 31, 2027 | UDEH-MOMOH, CHINEDU THERESA | reporter.nih.gov |
| Center for Integrative Research on Childhood Adversity | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $7,585,611 | August 1, 2016 | June 30, 2027 | CROFF, JULIE MAY | reporter.nih.gov |
| University of Arizona Cancer Prevention Clinical Trials Network | NIH | National Cancer Institute | 2021 to 2025 | $7,572,043 | August 16, 2019 | July 31, 2031 | THOMPSON, PATRICIA ANN | reporter.nih.gov |
| eMERGE Administrative Supplement 2025-2026 | NIH | National Human Genome Research Institute | 2021 to 2025 | $7,570,032 | August 1, 2025 | April 30, 2027 | HAKONARSON, HAKON | reporter.nih.gov |
| ACE-D: Accelerating Cognition-guided signatures to Enhance translation in Depression | NIH | National Institute of Mental Health | 2024 to 2025 | $7,556,428 | May 3, 2024 | February 28, 2029 | WILLIAMS, LEANNE | reporter.nih.gov |
| Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $7,542,201 | August 14, 2014 | July 31, 2026 | PANIKKAR, RAJIV | reporter.nih.gov |
| Ad26 Based Therapeutic Vaccines for HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,518,476 | May 12, 2020 | April 30, 2027 | BAROUCH, DAN H. | reporter.nih.gov |
| The Biostatistics Research Center for the Impaired Awareness of Hypoglycemia Consortium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $7,517,806 | September 25, 2022 | December 31, 2027 | CHINCHILLI, VERNON M | reporter.nih.gov |
| Health Systems Node of the NIDA Clinical Trials Network (CTN Project: CTN-141 Hlth Ins Instability) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,514,766 | March 1, 2025 | February 29, 2032 | CAMPBELL, CYNTHIA I | reporter.nih.gov |
| Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,505,536 | September 1, 2021 | July 31, 2027 | DAUBERT, MELISSA | reporter.nih.gov |
| NSF Quantum Technologies Engine in Connecticut (QuantumCT) | NSF | Regional Innovation Section | 2026 | $7,500,000 | August 1, 2026 | July 31, 2036 | S. Pamir Alpay | nsf.gov |
| NSF IMPACT Engine in Indiana | NSF | Regional Innovation Section | 2026 | $7,500,000 | August 1, 2026 | July 31, 2036 | James G Lancaster | nsf.gov |
| NSF Grid Modernization Engine in the Carolinas | NSF | Regional Innovation Section | 2026 | $7,500,000 | August 1, 2026 | July 31, 2036 | John L Daniels | nsf.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Johns Hopkins University | Baltimore, MD | 375 | $997.4 million | 1 | $69,525 |
| University of California Los Angeles | Los Angeles, CA | 213 | $976.3 million | 1 | $49,949 |
| Fred Hutchinson Cancer Center | Seattle, WA | 97 | $927.5 million | 0 | $0 |
| Duke University | Durham, NC | 288 | $878.1 million | 1 | $18,896 |
| University of California, San Francisco | San Francisco, CA | 391 | $745.9 million | 0 | $0 |
| Yale University | New Haven, CT | 263 | $671.4 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 331 | $658.4 million | 1 | $372,858 |
| Massachusetts General Hospital | Boston, MA | 365 | $656 million | 0 | $0 |
| Washington University | Saint Louis, MO | 258 | $629.8 million | 0 | $0 |
| Emory University | Atlanta, GA | 227 | $615.6 million | 1 | $514,277 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 313 | $609.6 million | 4 | $2.1 million |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 301 | $582.8 million | 1 | $423,618 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 172 | $550.3 million | 0 | $0 |
| Stanford University | Stanford, CA | 282 | $520.7 million | 2 | $1.1 million |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 235 | $506.5 million | 2 | $521,175 |
| University of Washington | Seattle, WA | 229 | $503.3 million | 1 | $325,000 |
| Columbia University Health Sciences | New York, NY | 207 | $503.5 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 173 | $483.9 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 153 | $448.6 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 138 | $444.4 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 207 | $424 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 212 | $387.9 million | 3 | $10.1 million |
| University of Wisconsin-Madison | Madison, WI | 143 | $392.8 million | 2 | $1.4 million |
| Northwestern University at Chicago | Chicago, IL | 168 | $377.8 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 158 | $333.7 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 179 | $328.5 million | 1 | $299,997 |
| University of Colorado Denver | Aurora, CO | 209 | $299.3 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 100 | $297.7 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 139 | $292.9 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 185 | $269.2 million | 1 | $19.6 million |
| University of Utah | Salt Lake City, UT | 159 | $280.6 million | 1 | $619,000 |
| Weill Medical Coll of Cornell Univ | New York, NY | 122 | $279.9 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 51 | $278.3 million | 0 | $0 |
| University of California at Davis | Davis, CA | 114 | $274.5 million | 3 | $2.8 million |
| Ohio State University | Columbus, OH | 162 | $265.9 million | 2 | $280,769 |
| University of Florida | Gainesville, FL | 155 | $252.5 million | 2 | $789,151 |
| Baylor College of Medicine | Houston, TX | 113 | $252.1 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 109 | $243.8 million | 3 | $1.7 million |
| Ut Southwestern Medical Center | Dallas, TX | 128 | $239.4 million | 0 | $0 |
| University of Chicago | Chicago, IL | 94 | $235.1 million | 1 | $101,598 |
| University of Maryland Baltimore | Baltimore, MD | 109 | $232.4 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 89 | $200.4 million | 1 | $30.2 million |
| PPD Development LP | Wilmington, NC | 3 | $230 million | 0 | $0 |
| Research Triangle Institute | Research Triangle Park, NC | 43 | $219.8 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 93 | $211.1 million | 1 | $7.5 million |
| Family Health International | Durham, NC | 2 | $215.6 million | 0 | $0 |
| ST. Jude Children's Research Hospital | Memphis, TN | 45 | $213.1 million | 0 | $0 |
| Benaroya Research Inst at Virginia Mason | Seattle, WA | 3 | $204.7 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 78 | $202.9 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 119 | $199.4 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 28 | $198.8 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 102 | $184.8 million | 0 | $0 |
| Public Health Institute | Oakland, CA | 3 | $171.4 million | 0 | $0 |
| University of Rochester | Rochester, NY | 77 | $163.8 million | 1 | $7.5 million |
| Children's Hosp of Philadelphia | Philadelphia, PA | 91 | $166.6 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 102 | $165.6 million | 1 | $387,628 |
| University of Arizona | Tucson, AZ | 74 | $160.5 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 94 | $156.3 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 83 | $154.5 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 79 | $151.7 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 92 | $149.8 million | 1 | $240,470 |
| University of South Florida | Tampa, FL | 39 | $150 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 87 | $149.4 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 63 | $147.9 million | 0 | $0 |
| Westat, Inc. | Bethesda, MD | 4 | $147 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 64 | $142.9 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 61 | $139.5 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 42 | $134.5 million | 2 | $2.4 million |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 83 | $133.3 million | 0 | $0 |
| Sri International | Menlo Park, CA | 11 | $132.2 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 60 | $131.7 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 79 | $128.8 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 78 | $124.7 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 68 | $124.3 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 57 | $124 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 46 | $123.8 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 55 | $121.3 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 51 | $120.4 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 78 | $116.9 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 63 | $115 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 90 | $107.8 million | 0 | $0 |
| Northern California Institute/res/edu | San Francisco, CA | 9 | $106.9 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 50 | $100.9 million | 0 | $0 |
| George Washington University | Washington, DC | 32 | $100 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 47 | $98.9 million | 0 | $0 |
| Ecog-Acrin Medical Research Foundation | Philadelphia, PA | 2 | $98.2 million | 0 | $0 |
| Brown University | Providence, RI | 57 | $91.4 million | 2 | $6.3 million |
| University of Georgia Research Foundation Inc | Athens, GA | 30 | $94 million | 2 | $419,752 |
| University of Cincinnati | Cincinnati, OH | 37 | $91.5 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 56 | $84.3 million | 5 | $7.1 million |
| University of Texas Med BR Galveston | Galveston, TX | 40 | $89.6 million | 0 | $0 |
| Ctis, Inc. | Rockville, MD | 1 | $86.9 million | 0 | $0 |
| Technical Resources International, Inc. | Bethesda, MD | 4 | $86.7 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 44 | $85.7 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 38 | $85.3 million | 0 | $0 |
| Tufts University Boston | Boston, MA | 21 | $85.3 million | 0 | $0 |
| Jaeb Center for Health Research, Inc. | Tampa, FL | 4 | $83.1 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 34 | $80.3 million | 2 | $584,980 |
| SUNY at Buffalo | Amherst, NY | 57 | $77.6 million | 0 | $0 |
| NRG Oncology Foundation, Inc. | Philadelphia, PA | 2 | $76.7 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 89 | $280,517,273 |
| 2025 | 16,081 | $11,744,181,883 | 142 | $133,676,830 |
| 2024 | 11,578 | $8,600,284,635 | 16 | $127,356,824 |
| 2023 | 7,954 | $6,722,695,288 | 10 | $12,386,856 |
| 2022 | 5,202 | $5,313,299,996 | 2 | $8,214,677 |
| 2021 | 3,082 | $3,594,086,149 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.